Amidst the COVID-19 pandemic, there has been an evident surge in the demand for high quality cell therapies intended for research and therapeutic purposes, presenting lucrative opportunities for consumable providers having capabilities for raw material production
Roots Analysis has announced the addition of the “Cell Therapy Consumables Market, 2021 – 2031” report to its list of offerings.
Currently, more than 800 IND applications have been filed for cell therapies, while close to 10 cell-based / gene therapies are likely to receive approval in 2021 across the world. This has prompted several drug developers to rely on third-party service providers that claim to have the required skillset and technical infrastructure for the production of raw materials, such as cell culture medium, cell isolation kits and cell separation reagents, in order to produce quality cellular therapies.
To order this 230+ page report, which features 110+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html